ID   SGK2_HUMAN              Reviewed;         367 AA.
AC   Q9HBY8; Q52PK5; Q5H8Y6; Q5H8Z1; Q5TZR3; Q9UKG6;
DT   22-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2021, sequence version 2.
DT   12-OCT-2022, entry version 183.
DE   RecName: Full=Serine/threonine-protein kinase Sgk2;
DE            EC=2.7.11.1;
DE   AltName: Full=Serum/glucocorticoid-regulated kinase 2;
GN   Name=SGK2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), TISSUE SPECIFICITY,
RP   PHOSPHORYLATION AT THR-193, AND MUTAGENESIS OF SER-356.
RX   PubMed=10548550; DOI=10.1042/bj3440189;
RA   Kobayashi T., Deak M., Morrice N., Cohen P.;
RT   "Characterization of the structure and regulation of two novel isoforms of
RT   serum- and glucocorticoid-induced protein kinase.";
RL   Biochem. J. 344:189-197(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Li H., Nong W., Zhou G., Ke R., Shen C., Zhong G., Zheng Z., Liang M.,
RA   Xiao W., Lin L., Yang S.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION IN THE REGULATION OF NA(+)/K(+) ATPASE.
RX   PubMed=12590200; DOI=10.1159/000068699;
RA   Henke G., Setiawan I., Boehmer C., Lang F.;
RT   "Activation of Na+/K+-ATPase by the serum and glucocorticoid-dependent
RT   kinase isoforms.";
RL   Kidney Blood Press. Res. 25:370-374(2002).
RN   [7]
RP   FUNCTION.
RX   PubMed=12397388; DOI=10.1007/s00424-002-0873-2;
RA   Gamper N., Fillon S., Feng Y., Friedrich B., Lang P.A., Henke G.,
RA   Huber S.M., Kobayashi T., Cohen P., Lang F.;
RT   "K(+) channel activation by all three isoforms of serum- and
RT   glucocorticoid-dependent protein kinase SGK.";
RL   Pflugers Arch. 445:60-66(2002).
RN   [8]
RP   FUNCTION IN THE REGULATION OF KCNE1 AND KCNQ1.
RX   PubMed=12634932; DOI=10.1007/s00424-002-0982-y;
RA   Embark H.M., Boehmer C., Vallon V., Luft F., Lang F.;
RT   "Regulation of KCNE1-dependent K(+) current by the serum and
RT   glucocorticoid-inducible kinase (SGK) isoforms.";
RL   Pflugers Arch. 445:601-606(2003).
RN   [9]
RP   FUNCTION IN THE REGULATION OF SCNN1A/ENAC.
RX   PubMed=12632189; DOI=10.1007/s00424-002-0993-8;
RA   Friedrich B., Feng Y., Cohen P., Risler T., Vandewalle A., Broeer S.,
RA   Wang J., Pearce D., Lang F.;
RT   "The serine/threonine kinases SGK2 and SGK3 are potent stimulators of the
RT   epithelial Na+ channel alpha,beta,gamma-ENaC.";
RL   Pflugers Arch. 445:693-696(2003).
RN   [10]
RP   FUNCTION IN THE REGULATION OF KCNA3/KV1.3.
RX   PubMed=15040001; DOI=10.1002/jcp.10430;
RA   Henke G., Maier G., Wallisch S., Boehmer C., Lang F.;
RT   "Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin ligase
RT   Nedd4-2 and the serum and glucocorticoid inducible kinase SGK1.";
RL   J. Cell. Physiol. 199:194-199(2004).
RN   [11]
RP   FUNCTION IN THE REGULATION OF SLC6A19.
RX   PubMed=20511718; DOI=10.1159/000315092;
RA   Boehmer C., Sopjani M., Klaus F., Lindner R., Laufer J., Jeyaraj S.,
RA   Lang F., Palmada M.;
RT   "The serum and glucocorticoid inducible kinases SGK1-3 stimulate the
RT   neutral amino acid transporter SLC6A19.";
RL   Cell. Physiol. Biochem. 25:723-732(2010).
RN   [12]
RP   FUNCTION IN THE REGULATION OF SLC9A3/NHE3, AND SUBCELLULAR LOCATION.
RX   PubMed=21865597; DOI=10.1091/mbc.e11-04-0328;
RA   He P., Lee S.J., Lin S., Seidler U., Lang F., Fejes-Toth G.,
RA   Naray-Fejes-Toth A., Yun C.C.;
RT   "Serum- and glucocorticoid-induced kinase 3 in recycling endosomes mediates
RT   acute activation of Na+/H+ exchanger NHE3 by glucocorticoids.";
RL   Mol. Biol. Cell 22:3812-3825(2011).
RN   [13]
RP   REVIEW.
RX   PubMed=16460280; DOI=10.1146/annurev.physiol.68.040104.131654;
RA   Loffing J., Flores S.Y., Staub O.;
RT   "Sgk kinases and their role in epithelial transport.";
RL   Annu. Rev. Physiol. 68:461-490(2006).
RN   [14]
RP   REVIEW ON FUNCTION.
RX   PubMed=20919962; DOI=10.3109/08977194.2010.518616;
RA   Bruhn M.A., Pearson R.B., Hannan R.D., Sheppard K.E.;
RT   "Second AKT: the rise of SGK in cancer signalling.";
RL   Growth Factors 28:394-408(2010).
RN   [15]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-199 AND TYR-289, AND VARIANT THR-12
RP   (ISOFORM 2).
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine-protein kinase which is involved in the
CC       regulation of a wide variety of ion channels, membrane transporters,
CC       cell growth, survival and proliferation. Up-regulates Na(+) channels:
CC       SCNN1A/ENAC, K(+) channels: KCNA3/Kv1.3, KCNE1 and KCNQ1, amino acid
CC       transporter: SLC6A19, glutamate transporter: SLC1A6/EAAT4, glutamate
CC       receptors: GRIA1/GLUR1 and GRIK2/GLUR6, Na(+)/H(+) exchanger:
CC       SLC9A3/NHE3, and the Na(+)/K(+) ATPase. {ECO:0000269|PubMed:12397388,
CC       ECO:0000269|PubMed:12590200, ECO:0000269|PubMed:12632189,
CC       ECO:0000269|PubMed:12634932, ECO:0000269|PubMed:15040001,
CC       ECO:0000269|PubMed:20511718, ECO:0000269|PubMed:21865597}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- ACTIVITY REGULATION: Two specific sites, one in the kinase domain (Thr-
CC       193) and the other in the C-terminal regulatory region (Ser-356), need
CC       to be phosphorylated for its full activation.
CC   -!- INTERACTION:
CC       Q9HBY8; P08238: HSP90AB1; NbExp=2; IntAct=EBI-3914329, EBI-352572;
CC       Q9HBY8-2; Q9BW71: HIRIP3; NbExp=5; IntAct=EBI-12143041, EBI-723624;
CC       Q9HBY8-2; O15305: PMM2; NbExp=5; IntAct=EBI-12143041, EBI-10182608;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21865597}. Nucleus
CC       {ECO:0000269|PubMed:21865597}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=alpha;
CC         IsoId=Q9HBY8-2; Sequence=Displayed;
CC       Name=2; Synonyms=beta;
CC         IsoId=Q9HBY8-1; Sequence=VSP_060876;
CC       Name=3;
CC         IsoId=Q9HBY8-3; Sequence=VSP_060877;
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver, kidney and pancreas, and
CC       at lower levels in brain. {ECO:0000269|PubMed:10548550}.
CC   -!- PTM: Activated by phosphorylation on Ser-356 by an unknown kinase (may
CC       be mTORC2 but not confirmed), transforming it into a substrate for
CC       PDPK1 which then phosphorylates it on Thr-193.
CC       {ECO:0000269|PubMed:10548550}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- CAUTION: Not regulated by serum or glucocorticoids. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF169034; AAF12757.2; -; mRNA.
DR   EMBL; AF186470; AAG17012.1; -; mRNA.
DR   EMBL; AY987010; AAX88805.1; -; mRNA.
DR   EMBL; BT020098; AAV38901.1; -; mRNA.
DR   EMBL; Z98752; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014037; AAH14037.3; -; mRNA.
DR   EMBL; BC065511; AAH65511.1; -; mRNA.
DR   CCDS; CCDS13320.1; -. [Q9HBY8-2]
DR   CCDS; CCDS13321.1; -. [Q9HBY8-2]
DR   RefSeq; NP_001186193.1; NM_001199264.1. [Q9HBY8-2]
DR   RefSeq; NP_057360.2; NM_016276.3. [Q9HBY8-1]
DR   RefSeq; NP_733794.1; NM_170693.2. [Q9HBY8-2]
DR   AlphaFoldDB; Q9HBY8; -.
DR   SMR; Q9HBY8; -.
DR   BioGRID; 115416; 28.
DR   IntAct; Q9HBY8; 20.
DR   STRING; 9606.ENSP00000340608; -.
DR   BindingDB; Q9HBY8; -.
DR   ChEMBL; CHEMBL5794; -.
DR   GuidetoPHARMACOLOGY; 1535; -.
DR   iPTMnet; Q9HBY8; -.
DR   PhosphoSitePlus; Q9HBY8; -.
DR   BioMuta; SGK2; -.
DR   DMDM; 28558166; -.
DR   jPOST; Q9HBY8; -.
DR   MassIVE; Q9HBY8; -.
DR   MaxQB; Q9HBY8; -.
DR   PaxDb; Q9HBY8; -.
DR   PeptideAtlas; Q9HBY8; -.
DR   PRIDE; Q9HBY8; -.
DR   ProteomicsDB; 81612; -. [Q9HBY8-1]
DR   ProteomicsDB; 81613; -. [Q9HBY8-2]
DR   ProteomicsDB; 81614; -. [Q9HBY8-3]
DR   Antibodypedia; 1638; 324 antibodies from 31 providers.
DR   DNASU; 10110; -.
DR   Ensembl; ENST00000341458.10; ENSP00000340608.5; ENSG00000101049.18. [Q9HBY8-2]
DR   Ensembl; ENST00000373100.7; ENSP00000362192.1; ENSG00000101049.18. [Q9HBY8-2]
DR   Ensembl; ENST00000423407.7; ENSP00000392795.3; ENSG00000101049.18. [Q9HBY8-2]
DR   Ensembl; ENST00000426287.3; ENSP00000412214.2; ENSG00000101049.18. [Q9HBY8-2]
DR   GeneID; 10110; -.
DR   KEGG; hsa:10110; -.
DR   MANE-Select; ENST00000373100.7; ENSP00000362192.1; NM_170693.3; NP_733794.1.
DR   UCSC; uc002xkr.4; human. [Q9HBY8-2]
DR   CTD; 10110; -.
DR   DisGeNET; 10110; -.
DR   GeneCards; SGK2; -.
DR   HGNC; HGNC:13900; SGK2.
DR   HPA; ENSG00000101049; Tissue enhanced (intestine, kidney, liver).
DR   MIM; 607589; gene.
DR   neXtProt; NX_Q9HBY8; -.
DR   OpenTargets; ENSG00000101049; -.
DR   VEuPathDB; HostDB:ENSG00000101049; -.
DR   eggNOG; KOG0598; Eukaryota.
DR   GeneTree; ENSGT00940000153776; -.
DR   InParanoid; Q9HBY8; -.
DR   OrthoDB; 614710at2759; -.
DR   PhylomeDB; Q9HBY8; -.
DR   TreeFam; TF320906; -.
DR   PathwayCommons; Q9HBY8; -.
DR   Reactome; R-HSA-2672351; Stimuli-sensing channels.
DR   SignaLink; Q9HBY8; -.
DR   SIGNOR; Q9HBY8; -.
DR   BioGRID-ORCS; 10110; 11 hits in 1106 CRISPR screens.
DR   ChiTaRS; SGK2; human.
DR   GeneWiki; SGK2; -.
DR   GenomeRNAi; 10110; -.
DR   Pharos; Q9HBY8; Tchem.
DR   PRO; PR:Q9HBY8; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9HBY8; protein.
DR   Bgee; ENSG00000101049; Expressed in mucosa of transverse colon and 141 other tissues.
DR   ExpressionAtlas; Q9HBY8; baseline and differential.
DR   Genevisible; Q9HBY8; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0017080; F:sodium channel regulator activity; TAS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IBA:GO_Central.
DR   GO; GO:0032411; P:positive regulation of transporter activity; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0001558; P:regulation of cell growth; TAS:UniProtKB.
DR   GO; GO:0042127; P:regulation of cell population proliferation; TAS:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; TAS:ProtInc.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..367
FT                   /note="Serine/threonine-protein kinase Sgk2"
FT                   /id="PRO_0000086646"
FT   DOMAIN          35..292
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          293..367
FT                   /note="AGC-kinase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           68..78
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        159
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         41..49
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         64
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         10
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8R4U9"
FT   MOD_RES         193
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000269|PubMed:10548550"
FT   MOD_RES         334
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   MOD_RES         356
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   MOD_RES         357
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00618"
FT   VAR_SEQ         1
FT                   /note="M -> MQGLLTSGRKPSGGGRCTGRGGWRGQWCLKPWMGGADPPTPTLSCLL
FT                   LPVPPELPDHCYRM (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060876"
FT   VAR_SEQ         1
FT                   /note="M -> MQGLLTSGRKPSGGGRCTELPDHCYRM (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_060877"
FT   VARIANT         199
FT                   /note="E -> K (in a lung adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041074"
FT   VARIANT         289
FT                   /note="H -> Y (in dbSNP:rs35793869)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041075"
FT   MUTAGEN         356
FT                   /note="S->D: Increased activation."
FT                   /evidence="ECO:0000269|PubMed:10548550"
FT   CONFLICT        108
FT                   /note="K -> E (in Ref. 2; AAX88805)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        148
FT                   /note="G -> D (in Ref. 3; AAV38901)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        277
FT                   /note="L -> P (in Ref. 2; AAX88805)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         Q9HBY8-1:12
FT                   /note="S -> T (in dbSNP:rs33969356)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_083966"
SQ   SEQUENCE   367 AA;  41175 MW;  E53F1ABE253F648B CRC64;
     MNSSPAGTPS PQPSRANGNI NLGPSANPNA QPTDFDFLKV IGKGNYGKVL LAKRKSDGAF
     YAVKVLQKKS ILKKKEQSHI MAERSVLLKN VRHPFLVGLR YSFQTPEKLY FVLDYVNGGE
     LFFHLQRERR FLEPRARFYA AEVASAIGYL HSLNIIYRDL KPENILLDCQ GHVVLTDFGL
     CKEGVEPEDT TSTFCGTPEY LAPEVLRKEP YDRAVDWWCL GAVLYEMLHG LPPFYSQDVS
     QMYENILHQP LQIPGGRTVA ACDLLQSLLH KDQRQRLGSK ADFLEIKNHV FFSPINWDDL
     YHKRLTPPFN PNVTGPADLK HFDPEFTQEA VSKSIGCTPD TVASSSGASS AFLGFSYAPE
     DDDILDC
//
